HilleVax Inc.



Market open

 --Real time quotes

Oct 4, 2022, 11:56 a.m.





-0.43 -2.35%


Volume 4,655

Real time quotes


Previous close

$ 18.33

$ 17.90


-0.43 -2.35%

Day low

Day high




52 week low

52 week high




David A. Socks

Founder of 16 different companies, notably: Mallinckrodt Hospital Products, Inc., Arcutis Biotherapeutics, Inc. and Phathom Pharmaceuticals, Inc. David A. Socks is an entrepreneur and businessperson who has been the head of 8 different companies and currently is Chairman of Eleusis Holdings Ltd., Chairman at Eleusis Holdings Ltd., Chief Financial & Business Officer at HilleVax, Inc. and Venture Partner at Frazier Management LLC. David A. Socks is also on the board of Phathom Pharmaceuticals, Inc. (former Chief Financial Officer, Treasurer & Director).

In his past career Mr. Socks occupied the position of Director at Recida Therapeutics, Inc. (he founded the company), Chief Executive Office at Nexcida Therapeutics, Inc. (he founded the company), Director at Outpost Medicine, Inc. (he founded the company in 2016), Chief Executive Officer of Scout Bio, Inc. (he founded the company), Vice President-Finance of CelTor Biosystems, Inc., Vice President-Business Development at Kanisa Pharmaceuticals, Inc. (he founded the company in 2009), Advisor at Windamere Venture Partners LLC, Senior Manager at Kaiser Associates, Inc., Senior VP-Corporate Development & Strategy at Cadence Pharmaceuticals, Inc. (he founded the company in 2004), President & Chief Operating Officer of Incline Therapeutics, Inc. (he founded the company in 2010) and Senior VP-Corporate Development & Strategy at Mallinckrodt Hospital Products, Inc. (he founded the company in 2010).

Mr. Socks received an undergraduate degree from Georgetown University and an MBA from Stanford University.


Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. David A. Socks
Chief Financial & Business Officer
Dr. Astrid Borkowski
Chief Medical Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Dr. Gary Dubin
Ms. Kaia Agarwal
Senior Vice President-Regulatory Affairs
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Ms. Susan Silbermann
Independent Director
Link to MarketWatch's Slice.